Donald M. O'Rourke
University of Pennsylvania
H-index: 65
North America-United States
Top articles of Donald M. O'Rourke
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Brain-wide neuronal circuit connectome of human glioblastoma | bioRxiv | Yusha Sun Xin Wang Daniel Y Zhang Zhijian Zhang Janardhan P Bhattarai | 2024 |
Armored Bicistronic CAR T Cells with Dominant-negative TGF-β Receptor II to Overcome Resistance in Glioblastoma. | bioRxiv | Nannan Li Jesse L Rodriguez Yibo Yin Meghan T Logun Shengkun Yu | 2024 |
Live Organoid Cyclic Imaging | Advanced Science | David E Reynolds Yusha Sun Xin Wang Phoebe Vallapureddy Jianhua Lim | 2024/2/7 |
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results | Nature Medicine | Stephen J Bagley Meghan Logun Joseph A Fraietta Xin Wang Arati S Desai | 2024/3/13 |
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial | Nature Cancer | Stephen J Bagley Zev A Binder Lamia Lamrani Eliana Marinari Arati S Desai | 2024/1/12 |
Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approach | Scientific Reports | Jun Guo Anahita Fathi Kazerooni Erik Toorens Hamed Akbari Fanyang Yu | 2024/2/28 |
1142 mRNA LNP vaccination with the tumor-specific antigen EGFRvIII bolsters CAR T cell activity in vivo | J Immunother | Jesse L Rodriguez Tyler E Papp Logan Zhang Kelly A Hicks Hamideh Parhiz | 2023 |
Distinguishing progression from pseudoprogression in glioblastoma using 18F-fluciclovine PET | Journal of Nuclear Medicine | Ali Nabavizadeh Stephen J Bagley Robert K Doot Jeffrey B Ware Anthony J Young | 2022/12/1 |
Optimizing CAR-T Therapy for Glioblastoma | Oliver Y Tang Zev A Binder Donald M O’Rourke Stephen J Bagley | 2023/11 | |
Corrigendum to: EGFR, the Lazarus target for precision oncology in glioblastoma | Neuro-oncology | Benjamin Lin Julia Ziebro Erin Smithberger Kasey R Skinner Eva Zhao | 2023/1 |
Abstract LB026: Porcine brain-derived hydrogel carriers for intratumoral administration of cellular immunotherapies enhances anti-tumor potential in post-resection GBM | Cancer Research | Meghan Logun Zev Binder Donald O'Rourke | 2023/4/14 |
NIMG-13. ROBUSTNESS OF PROGNOSTIC STRATIFICATION IN DE NOVO GLIOBLASTOMA PATIENTS ACROSS 22 GEOGRAPHICALLY DISTINCT INSTITUTIONS: INSIGHTS FROM THE RESPOND CONSORTIUM | Neuro-Oncology | Hamed Akbari Spyridon Bakas Jose Garcia Anahita Fathi Kazerooni Chiharu Sako | 2023/11/1 |
MODL-05. ELUCIDATING THE EPIGENETIC DRIVEN TRANSCRIPTIONAL PROGRAM UNDERLYING THE INVASIVE PHENOTYPE OF THE NOVEL EGFRA289VARIANT OF GBM | Neuro-Oncology | Benjamin Lin Julia Ziebro Abigail Shelton Kasey Skinner Ryan Bash | 2023/11/1 |
Non-Invasive Assessment of Isocitrate Dehydrogenase-Mutant Gliomas Using Optimized Proton Magnetic Resonance Spectroscopy on a Routine Clinical 3-Tesla MRI | Cancers | Laiz Laura de Godoy Kheng Choon Lim Archith Rajan Gaurav Verma Mauro Hanaoka | 2023/9/7 |
Abstract LB097: Armored bicistronic CAR T cells with dominant-negative TGF-β receptor II to alleviate antigenic heterogeneity and suppressive immune microenvironment in … | Cancer Research | Nannan Li Jesse Rodriguez Zev Binder Donald O’Rourke | 2023/4/14 |
NIMG-39. BENCHMARKING MULTI-LABEL PREDICTION OF TARGET GENE MUTATION STATUS IN GLIOBLASTOMA USING RADIOGENOMICS AND MULTI-PARAMETRIC MR IMAGING | Neuro-Oncology | Fanyang Yu Jun Guo Anahita Fathi Kazerooni Hamed Akbari Erik Toorens | 2023/11/1 |
Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric mri-based prediction model | Journal of Neuro-Oncology | Laiz Laura de Godoy Sanjeev Chawla Steven Brem Sumei Wang Donald M O’Rourke | 2023/5 |
Non-invasive Assessment of IDH-mutant Gliomas Using Optimized Proton Magnetic Resonance Spectroscopy on a Routine Clinical 3-Tesla MRI | Laiz Laura De Godoy Kheng Choon Lim Archith Rajan Gaurav Verma Mauro Hanaoka | 2023/8/21 | |
282 Dual antigen targeting CAR T cells armored with a dominant-negative TGF-β Receptor II enhance antitumor potency by overcoming TGF-β immunosuppression in GBM | Nannan Li Jesse Rodriguez Zev Binder Donald O’Rourke | 2023/11/1 | |
Phase I study of repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab in patients with newly diagnosed, MGMT-unmethylated glioblastoma | Stephen J Bagley Zev A Binder Arati S Desai Maclean P Nasrallah Eileen Maloney | 2023/3/28 |
Co-Authors
